Financial Assistance
Newsletter Sign-up
Need Appointment
Contact Us
About Us

Rush University
For Physicians
For Rush Employees
For Students
Bill Payment Center
Rotate
<< Previous | New Search | Return to Search Results | Next >>

John Segreti, MD

John Segreti, MD
Appointment Request

Or call
(888) 352-RUSH for help arranging an appointment.
Specialty:
  • Infectious Disease
  • Internal Medicine
Board Certification:
  • Infectious Disease
  • Internal Medicine
Faculty Rank: Professor
Medical or Graduate Education: Rush Medical College
Residency: Rush University Medical Center - Internal Medicine
Fellowship: Rush University Medical Center - Infectious Disease
Clinical Expertise:
  • Antibiotic resistance
  • Nosocomial infections
  • Osteomyelitis
Research Interests:
  • Antibiotic resistance
  • Nosocomial infections
Languages Spoken:
  • English
  • Spanish
Google Map
  • University Infectious Diseases
  • Academic Facility
  • 600 S. Paulina St.
  • Suite 140
  • Chicago, IL  60612
  • Phone: (312) 942-5865
  • Fax: (312) 942-8200
  • View Larger MapDriving Directions

Below is a list of scientific publications for which this practitioner was either the primary author or a contributor. Citations come from PubMed, a database of biomedical literature, life science journals and online books. PubMed is a service of the US Library of Medicine at the National Institutes of Health. Click on the title of the cited work for more information (this will take you directly to PubMed.gov). Listings go back five years.

  1. Multicenter study of high-dose daptomycin for treatment of enterococcal infections.
    Casapao AM, Kullar R, Davis SL, Levine DP, Zhao JJ, Potoski BA, Goff DA, Crank CW, Segreti J, Sakoulas G, Cosgrove SE, Rybak MJ
    Antimicrob. Agents Chemother.
    2013 Sep
    57(9):4190-6.
    eng
  2. Should Draining Wounds and Sinuses Associated With Hip and Knee Arthroplasties Be Cultured?
    Tetreault MW, Wetters NG, Aggarwal VK, Moric M, Segreti J, Huddleston, Parvizi J, Della Valle CJ
    J Arthroplasty
    2013 Jul 29
    :.
    ENG
  3. A multicentre evaluation of the effectiveness and safety of high-dose daptomycin for the treatment of infective endocarditis.
    Kullar R, Casapao AM, Davis SL, Levine DP, Zhao JJ, Crank CW, Segreti J, Sakoulas G, Cosgrove SE, Rybak MJ
    J. Antimicrob. Chemother.
    2013 Aug 8
    :.
    ENG
  4. Challenges in assessing microbial susceptibility and predicting clinical response to newer-generation fluoroquinolones.
    Segreti J, Jones RN, Bertino JS Jr.
    J Ocul Pharmacol Ther. 2012
    2012 Feb
    28(1):3-11. doi: 10.1089/jop.2011.0072. Epub 2011 Oct 14. Review.
  5. Consensus conference on prevention of central line-associated bloodstream infections: 2009.
    Segreti J, Garcia-Houchins S, Gorski L, Moureau N, Shomo J, Zack J, Stachnik J, Tanzi M, Moody ML.
    J Infus Nurs. 2011
    2011 Mar-Apr
    34(2):126-33. doi: 10.1097/NAN.0b013e31820b8a3e.
  6. High-dose daptomycin for treatment of complicated gram-positive infections: a large, multicenter, retrospective study.
    Kullar R, Davis SL, Levine DP, Zhao JJ, Crank CW, Segreti J, Sakoulas G, Cosgrove SE, Rybak MJ.
    Pharmacotherapy. 2011
    2011 Jun
    31(6):527-36. doi: 10.1592/phco.31.6.527.
  7. American Academy of Orthopaedic Surgeons clinical practice guideline on: the diagnosis of periprosthetic joint infections of the hip and knee.
    Della Valle C, Parvizi J, Bauer TW, DiCesare PE, Evans RP, Segreti J, Spangehl M, Watters WC 3rd, Keith M, Turkelson CM, Wies JL, Sluka P, Hitchcock K; American Academy of Orthopaedic Surgeons.
    J Bone Joint Surg Am. 2011
    2011 Jul 20
    93(14):1355-7. doi: 10.2106/JBJS.9314ebo. No abstract available.
  8. Comparison of outcomes from daptomycin or linezolid treatment for vancomycin-resistant enterococcal bloodstream infection: A retrospective, multicenter, cohort study.
    Crank CW, Scheetz MH, Brielmaier B, Rose WE, Patel GP, Ritchie DJ, Segreti J.
    Clin Ther. 2010
    2010 Sep
    32(10):1713-9. doi: 10.1016/j.clinthera.2010.09.008.
  9. Microbiologic and clinical epidemiologic characteristics of the Chicago subset of a multistate outbreak of Serratia marcescens bacteremia.
    Sikka MK, Hayden MK, Pur S, Segreti J, Harris AA, Weinstein RA, Trenholme G.
    Infect Control Hosp Epidemiol. 2010
    2010 Nov
    31(11):1191-3. doi: 10.1086/657074.
  10. Osteomyelitis.
    Chihara S, Segreti J.
    Dis Mon. 2010
    2010 Jan
    56(1):5-31. doi: 10.1016/j.disamonth.2009.07.001. Review. No abstract available.
  11. Diagnosis of periprosthetic joint infections of the hip and knee.
    Della Valle C, Parvizi J, Bauer TW, Dicesare PE, Evans RP, Segreti J, Spangehl M, Watters WC 3rd, Keith M, Turkelson CM, Wies JL, Sluka P, Hitchcock K; American Academy of Orthopaedic Surgeons.
    J Am Acad Orthop Surg. 2010
    2010 Dec
    18(12):760-70.
  12. Review of question and answer session.
    Segreti J.
    Int J Antimicrob Agents. 2009
    2009 Jul
    34 Suppl 1:S36-8. doi: 10.1016/S0924-8579(09)70548-5. Review.
  13. Empirical therapy for serious Gram-positive infections: making the right choice
    Segreti J
    Clin Microbiol Infect
    2009 Dec
    15 Suppl 6:5-10
  14. University HealthSystem Consortium quality performance benchmarking study of the insertion and care of central venous catheters.
    Harting BP, Talbot TR, Dellit TH, Hebden J, Cuny J, Greene WH, Segreti J.
    Infect Control Hosp Epidemiol. 2008
    2008 May
    29(5):440-2. doi: 10.1086/587716.
  15. Is it bacterial or viral? Criteria for distinguishing bacterial and viral infections.
    Benninger M, Segreti J.
    J Fam Pract. 2008
    2008 Feb
    57(2 Suppl Managing):S5-11. Review. No abstract available.
  16. Health care-associated pneumonia (HCAP): a critical appraisal to improve identification, management, and outcomes--proceedings of the HCAP Summit.
    Kollef MH, Morrow LE, Baughman RP, Craven DE, McGowan JE Jr, Micek ST, Niederman MS, Ost D, Paterson DL, Segreti J.
    Clin Infect Dis. 2008
    2008 Apr 15
    46 Suppl 4:S296-334; quiz 335-8. doi: 10.1086/526355.
  17. Antibiotic therapy of methicillin-resistant Staphylococcus aureus in critical care.
    Tverdek FP, Crank CW, Segreti J.
    Crit Care Clin. 2008
    2008 Apr
    24(2):249-60, vii-viii. doi: 10.1016/j.ccc.2007.12.013.
  • (If you cannot play the video, you may need to update to the latest version of Adobe Flash Player.)
  • View Transcript

Find a Doctor | Patient & Visitor Services | Health Information | Clinical Services | Events & Classes | News Room | Clinical Trials | Research at Rush
Nursing at Rush | Work at Rush | Giving to Rush | Directions to Rush | Disclaimer | Privacy Statement
For Physicians | For Rush Employees | For Students | Bill Payment Center | Site Map
© Rush University Medical Center
1653 W. Congress Parkway, Chicago, Illinois 60612